Literature DB >> 33021324

Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.

Sivan Sheffer-Levi1, Amit Rimon, Vanda Lerer, Tehila Shlomov, Shunit Coppenhagen-Glazer, Chani Rakov, Tamara Zeiter, Ran Nir-Paz, Ronen Hazan, Vered Molho-Pessach.   

Abstract

Antibiotic-resistant Cutibacterium acnes has been reported worldwide, but data from Israeli patients with acne is currently lacking. This study evaluated the antibiotic susceptibility of C. acnes, isolated from 50 Israeli patients with acne to commonly prescribed antibiotics, using the Epsilometer test (E-test). Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) analysis, 16S rRNA sequencing and single locus sequence typing (SLST) molecular typing were used to identify and characterize C. acnes. Among 36 strains isolated, phylotype IA1 was most common. Resistance to at least one antibiotic was found in 30.6% of tested strains. Resistance rates were highest for erythromycin (25.0%), followed by doxycycline (19.4%), clindamycin (16.7%), minocycline (11.1%) and tetracycline (8.3%). Significant correlation was found between resistance to multiple antibiotics, with 5.6% of isolates resistant to all antibiotics tested. When reviewing resistances rate worldwide antibiotic resistance was found to be prevalent in Israel. Measures to limit the emergence of antibiotic-resistant strains of Cutibacterium acnes should be taken and alternative treatments should be sought.

Entities:  

Keywords:  Cutibacterium acnes; antibiotic; resistance; acne

Mesh:

Substances:

Year:  2020        PMID: 33021324      PMCID: PMC9274907          DOI: 10.2340/00015555-3654

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  40 in total

Review 1.  MALDI-TOF mass spectrometry of bacteria.

Authors:  J O Lay
Journal:  Mass Spectrom Rev       Date:  2001 Jul-Aug       Impact factor: 10.946

2.  Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.

Authors:  Cağri Ergin; Seniz Ergin; Ilknur Kaleli; Nida Kaçar; Mustafa Sengül; Berna S Erdoğan
Journal:  J Dermatol       Date:  2006-12       Impact factor: 4.005

3.  Antimicrobial susceptibility and phylogenetic analysis of Propionibacterium acnes isolated from acne patients in Japan between 2013 and 2015.

Authors:  Keisuke Nakase; Nobukazu Hayashi; Yui Akiyama; Sae Aoki; Norihisa Noguchi
Journal:  J Dermatol       Date:  2017-06-17       Impact factor: 4.005

Review 4.  Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne.

Authors:  Diane M Thiboutot; Brigitte Dréno; Abdullah Abanmi; Andrew F Alexis; Elena Araviiskaia; Maria Isabel Barona Cabal; Vincenzo Bettoli; Flordeliz Casintahan; Steven Chow; Adilson da Costa; Tam El Ouazzani; Chee-Leok Goh; Harald P M Gollnick; Minerva Gomez; Nobukazu Hayashi; Maria Isabel Herane; Juan Honeyman; Sewon Kang; Lajos Kemeny; Raj Kubba; Julien Lambert; Alison M Layton; James J Leyden; Jose Luis López-Estebaranz; Nopadon Noppakun; Falk Ochsendorf; Cristina Oprica; Beatriz Orozco; Montserrat Perez; Jaime Piquero-Martin; Jo-Ann See; Dae Hun Suh; Jerry Tan; Vicente Torres Lozada; Patricia Troielli; Leihong Flora Xiang
Journal:  J Am Acad Dermatol       Date:  2017-11-08       Impact factor: 11.527

5.  Bacterial resistance in French acne patients.

Authors:  G Dumont-Wallon; D Moyse; E Blouin; B Dréno
Journal:  Int J Dermatol       Date:  2010-03       Impact factor: 2.736

6.  Using the Physician Global Assessment in a clinical setting to measure and track patient outcomes.

Authors:  Vanessa L Pascoe; Monica Enamandram; Kristen C Corey; Carol E Cheng; Emilia J Javorsky; Sarah M Sung; Kevin R Donahue; Alexandra B Kimball
Journal:  JAMA Dermatol       Date:  2015-04       Impact factor: 10.282

7.  In vitro antimicrobial susceptibility patterns of Propionibacterium acnes isolated from patients with acne vulgaris.

Authors:  Indu Biswal; Rajni Gaind; Neeraj Kumar; Srujana Mohanty; Vikas Manchanda; Niti Khunger; Ramesh V; Monorama Deb
Journal:  J Infect Dev Ctries       Date:  2016-10-31       Impact factor: 0.968

8.  Antibiotic-resistant acne: lessons from Europe.

Authors:  J I Ross; A M Snelling; E Carnegie; P Coates; W J Cunliffe; V Bettoli; G Tosti; A Katsambas; J I Galvan Peréz Del Pulgar; O Rollman; L Török; E A Eady; J H Cove
Journal:  Br J Dermatol       Date:  2003-03       Impact factor: 9.302

9.  A novel high-resolution single locus sequence typing scheme for mixed populations of Propionibacterium acnes in vivo.

Authors:  Christian F P Scholz; Anders Jensen; Hans B Lomholt; Holger Brüggemann; Mogens Kilian
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

10.  Propionibacterium acnes strain populations in the human skin microbiome associated with acne.

Authors:  Sorel Fitz-Gibbon; Shuta Tomida; Bor-Han Chiu; Lin Nguyen; Christine Du; Minghsun Liu; David Elashoff; Marie C Erfe; Anya Loncaric; Jenny Kim; Robert L Modlin; Jeff F Miller; Erica Sodergren; Noah Craft; George M Weinstock; Huiying Li
Journal:  J Invest Dermatol       Date:  2013-01-21       Impact factor: 8.551

View more
  6 in total

Review 1.  Phage Therapy in Israel, Past, Present, and Future.

Authors:  Amit Rimon; Daniel Gelman; Ortal Yerushalmy; Shunit Coppenhagen-Glazer; Eyal Katvan; Ran Nir-Paz; Ronen Hazan
Journal:  Phage (New Rochelle)       Date:  2022-06-16

2.  Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology.

Authors:  Ayman Grada; Mahmoud A Ghannoum; Christopher G Bunick
Journal:  Antibiotics (Basel)       Date:  2022-05-27

Review 3.  Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation.

Authors:  Christopher G Bunick; Jonette Keri; S Ken Tanaka; Nika Furey; Giovanni Damiani; Jodi L Johnson; Ayman Grada
Journal:  Antibiotics (Basel)       Date:  2021-04-15

Review 4.  Part I Antimicrobial resistance: Bacterial pathogens of dermatologic significance and implications of rising resistance.

Authors:  Saira George; Fiorinda F Muhaj; Celine D Nguyen; Stephen K Tyring
Journal:  J Am Acad Dermatol       Date:  2022-02-02       Impact factor: 15.487

5.  Antibiotic Resistance Risk with Oral Tetracycline Treatment of Acne Vulgaris.

Authors:  Madisen A Swallow; Ryan Fan; Jeffrey M Cohen; Christopher G Bunick
Journal:  Antibiotics (Basel)       Date:  2022-07-30

Review 6.  A Janus-Faced Bacterium: Host-Beneficial and -Detrimental Roles of Cutibacterium acnes.

Authors:  Holger Brüggemann; Llanos Salar-Vidal; Harald P M Gollnick; Rolf Lood
Journal:  Front Microbiol       Date:  2021-05-31       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.